Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report Forecast 2017-2021

March 2017 | 125 pages | ID: G41EB6AE164EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report Forecast 2017-2021

1 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2021)
  1.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2021)
  1.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURING COST ANALYSIS

3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
  5.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
  5.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
  5.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Regions
  5.3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

6 UNITED STATES NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
  6.1.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
  6.1.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
  6.1.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
6.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

7 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
  7.1.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
  7.1.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
  7.1.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
7.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

8 EUROPE NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
  8.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
  8.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
8.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 JAPAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
  9.1.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
  9.1.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
9.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
9.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
9.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

10 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURERS ANALYSIS

10.1 Conatus Pharmaceuticals
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Daewoong Pharmaceutical
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Galmed International
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Kyorin Pharmaceutical
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Metabolic Solutions Development
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Novartis AG
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Phenex Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Raptor Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 TCM Biotech International
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET FORECAST (2017-2021)

13.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue Forecast (2017-2021)
13.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Regions (2017-2021)
13.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2021)
13.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales of Key Manufacturers (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Manufacturers (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Type (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application (2012-2017)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application (2012-2017)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Application (2012-2017)
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)
Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Galmed International Basic Information List
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)
Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Regions (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2021)
Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotech International, Tobira Therapeutics, Verva Pharmaceuticals, Zafgen